Calamos Advisors LLC Cv Rx, Inc. Transaction History
Calamos Advisors LLC
- $15.7 Billion
- Q1 2025
A detailed history of Calamos Advisors LLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, Calamos Advisors LLC holds 25,011 shares of CVRX stock, worth $187,582. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,011
Previous 10,596
136.04%
Holding current value
$187,582
Previous $134,000
127.61%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CVRX
# of Institutions
96Shares Held
15.5MCall Options Held
76.5KPut Options Held
6.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$30.8 Million17.73% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$15.2 Million1.83% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT921KShares$6.91 Million1.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA910KShares$6.82 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$6.57 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $154M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...